• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MXC
Click for more information
0.00% 2.1¢

MGC PHARMACEUTICALS LTD

Market Cap $57.29M  ! watchlist Created with Sketch. Add to my watchlist

MGC Pharmaceuticals is a European based ‘Seed to Medicine’ bio-pharma company focussed on... MGC Pharmaceuticals is a European based ‘Seed to Medicine’ bio-pharma company focussed on developing and commercialising phytocannabinoid derived medicines. The Company’s product offering currently targets two widespread medical conditions – epilepsy and dementia. Based in Europe, MGC Pharma is working to meet the growing demand for affordable high-quality phytocannabinoid medicines globally.More

PYG LEADING HCM SOLUTION

PayGroup is a leading provider of payroll and human capital management (HCM) solutions, delivering mission-critical services. Leveraging PYG’s deep regulatory and compliance expertise, PYG now proudly services enterprise clients in 82 countries, representing...

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
MXC
Ann: March 2022 Quarterly Activity and Cash Flow Reports 		18/05/22 26 7.4K
18/05/22 Last post  Footmax Comments Created with Sketch.  26  Views Created with Sketch.  7.4K 
MXC
Ann: Response to ASX Aware Query 		18/05/22 2 744
18/05/22 Last post  kurt64 Comments Created with Sketch.  2  Views Created with Sketch.  744 
MXC
Ann: s708A(5)(e) Cleansing Notice 		13/05/22 0 246
13/05/22 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  246 
MXC
Ann: Application for quotation of securities - MXC 		13/05/22 0 230
13/05/22 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  230 
MXC
Outlook for MXC
3 4 5
13/05/22 259 115K
13/05/22 Last post  StockObserver Comments Created with Sketch.  259  Views Created with Sketch.  115K 
MXC
News: MXC MGC Pharmaceuticals Says Patent Granted For Cannepil Snedds 		10/05/22 0 142
10/05/22 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  142 
MXC
Ann: Patent Granted for CannEpiL SNEDDS 		10/05/22 0 359
10/05/22 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  359 
MXC
Ann: Change of Director's Interest Notice x 2 		09/05/22 1 478
09/05/22 Last post  amb005 Comments Created with Sketch.  1  Views Created with Sketch.  478 

See All Discussions arrow Created with Sketch.

Timeline

Response to ASX Aware Query
18 May 09:07
 
s708A(5)(e) Cleansing Notice
13 May 19:03
 
Application for quotation of securities - MXC
13 May 19:01
 
Patent Granted for CannEpiL SNEDDS
10 May 16:41
 
Change of Director's Interest Notice x 2
09 May 08:23
 
March 2022 Quarterly Activity and Cash Flow Reports
29 Apr 18:31
 
View More arrow Created with Sketch.
(20min delay)
Trade with IG Advertisement
Last
2.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $57.29M
Open High Low Value Volume
2.1¢ 2.1¢ 2.1¢ $30.06K 1.431M

Buyers (Bids)

No. Vol. Price($)
9 458911 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 2828733 8
View Market Depth
Last trade - 16.10pm 20/05/2022 (20 minute delay) ?
(live)
Last
2.1¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
2.1¢ 2.2¢ 2.1¢ 724600
Last updated 15.52pm 20/05/2022 (live) ?
MXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.